Uncovering new approaches to target FOXR2 in pediatric cancers |
Children’s Hospital Los Angeles / Jessica Tsai, MD/PhD |
'A' Award Grants |
2024 |
California |
Collective cell invasion of fusion positive rhabdomyosarcoma regulated by PAX3-FOXO1 |
Children’s Hospital Los Angeles / Jinseok Park, PhD |
'A' Award Grants |
2024 |
California |
Targeting protein synthesis in pediatric acute myeloid leukemia |
Cincinnati Children's Hospital Medical Center / Courtney Jones, PhD |
'A' Award Grants |
2024 |
Ohio |
Unraveling GABAergic interneuron-like lineage in H3G34-mutant hemispheric high-grade gliomas: their impact on network formation and invasion |
Dana-Farber Cancer Institute / Gustavo Alencastro Veiga Cruzeiro, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Investigating the impact of osteosarcoma genetic lesions on bone differentiation |
Dana-Farber Cancer Institute / James Morrow, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Exploiting a Novel DNA Repair Defect in Ewing Sarcoma |
Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma |
Massachusetts General Hospital / Yueyang Wang, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics |
Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD |
Reach Grants |
2024 |
New York |
Direct targeting of oncoprotein assembly using mimetic peptide interference |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Innovation Grants |
2024 |
New York |